Crossmark

Mechanistic model of <scp>MAPK</scp> signaling reveals how allostery and rewiring contribute to drug resistance

Crossref DOI link: https://doi.org/10.15252/msb.202210988

Published Online: 2023-01-26

Published Print: 2023-02-10

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Fröhlich, Fabian https://orcid.org/0000-0002-5360-4292
Gerosa, Luca https://orcid.org/0000-0001-6805-9410
Muhlich, Jeremy https://orcid.org/0000-0002-0811-637X
Sorger, Peter K https://orcid.org/0000-0002-3364-1838
Funding

Funding for this research was provided by:

National Cancer Institute (U54‐CA225088)

Human Frontier Science Program (LT000259/2019‐L1)

Novartis Foundation
License Information

Version of Record valid from 2023-01-26
More Information

Publication History

Received: 2022-02-17

Accepted: 2022-12-15

Published: 2023-01-26